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ABSTRACT Both theoretical and experimental results are presented for the quantitative detection of calcium transients in
the perfused mouse heart loaded with the calcium-sensitive fluorescent dye Rhod-2. Analytical models are proposed to
calculate both the reflected absorbance and fluorescence spectra detected from the mouse heart. These models allow
correlation of the measured spectral intensities with the relative quantity of Rhod-2 in the heart and measurement of the
changes in quantum yield of Rhod-2 upon binding calcium in the heart in which multiple scattering effects are predominant.
Theoretical modeling and experimental results demonstrate that both reflected absorbance and fluorescence emission are
attenuated linearly with Rhod-2 washout. According to this relation, a ratiometric method using fluorescence and absorbance
is validated as a measure of the quantum yield of calcium-dependent fluorescence, enabling determination of the dynamics
of cytosolic calcium in the perfused mouse heart. The feasibility of this approach is confirmed by experiments quantifying
calcium transients in the perfused mouse heart stimulated at 8 Hz. The calculated cytosolic calcium concentrations are 368
68 nM and 654  164 nM in diastole and systole, respectively. Spectral distortions induced by tissue scattering and
absorption and errors induced by the geometry of the detection optics in the calcium quantification are shown to be
eliminated by using the ratio method. Methods to effectively minimize motion-induced artifacts and to monitor the oxygen-
ation status of the whole perfused heart are also discussed.
GLOSSARY
Nomenclature of tissue optics
 Optical wavelength;
a
 Optical absorption coefficient of tissue at ;
s
 Reduced scattering coefficient of tissue at ;
eff Effective attenuation coefficient: eff 
[3a(a  s)]1/2;
eff Effective penetration depth: eff  1/eff;
 Photon fluence rate in tissue;
A Absorbance spectrum;
A1,2 Differential absorbance between 1 and 2;
D Light diffusion coefficient: D  [3s]1;
mfp Reduced mean free path: mfp  [a 
s
]1;
R Diffuse reflectance from tissue;
S Photon source in tissue.
Calculation of fluorescence
x Excitation wavelength;
m Emission wavelength;
af
 Absorption coefficient of the fluorophore at ;
x,m Fluorescence quantum efficiency/yield for
emission at m, given excitation at x;
f Fluorescence photon fluence rate;
Em Escape function (or probability) of fluorescent
light;
Fx,m Fluorescence intensity from tissue emitted at
m, when excited at x;
Nx Excitation photon density;
Nf Fluorescent photon density;
Sm Fluorescent source emitted at m in tissue.
Calcium calculation and others
F Deflection angle of detector off the normal
direction of the incident beam;
F Solid angle of optical detector;
B Background fluorescence emission at ;
[Ca2]i Intracellular calcium concentration;
F Calcium-dependent fluorescence intensity;
F/A Ratio of fluorescence intensity over
differential absorbance between excitation and
detection wavelengths;
	F Calcium-dependent fluorescence transients
from diastole to systole;
G Geometric factor of optical detection system:
G  F/2cos F;
Kd Rhod-2 dissociation constant for calcium;
Mn2 Manganese chloride mixed in perfusate.
INTRODUCTION
Cytosolic free calcium (Ca2) is an important regulator of
cardiac metabolism and contractility. Fluorescence technol-
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ogy has demonstrated significant potential for detection of
Ca2 transients in perfused hearts (Fralix et al., 1990;
Brandes et al., 1992). Importantly, as most Ca2 indicators
have bright fluorescence emission, a minimal concentration
of fluorescent dye is required for Ca2 detection, thus
minimizing the potentially toxic buffering effects of the
calcium indicator on cardiac function.
Some of the calcium-sensitive fluorescent dyes, for in-
stance, Fura-2 and Indo-1, have been used to quantitatively
determine the concentration of intracellular calcium
([Ca2]i) in biological tissues and the heart (Brandes et al.,
1993; Haworth and Redon, 1998). These calcium indicators
require fluorescence excitation in the ultraviolet (UV)
range, where the overwhelming scattering and strong ab-
sorption of tissue substantially limits light penetration into
tissue. This is of particular significance to [Ca2]i measure-
ments in either the perfused heart or in vivo studies because
the tissue scattering and absorption by myoglobin, cyto-
chromes, and hemoglobin (in the presence of blood) restrict
the detection of Ca2-dependent fluorescence light to only
the outermost layers of the heart. In addition, changes in
scattering and absorbance associated with different physio-
logic states are large in the UV range.
Recently, calcium indicators excitable by visible light,
e.g., Rhod-2, have become commercially available. One
advantage of these fluorescent dyes over the UV-excitable
calcium indicators is a significant enhancement of fluores-
cence emission upon calcium binding. More importantly,
both excitation and emission of the Ca2-dependent fluo-
rescence are in the visible wavelength range, i.e., within the
so-called “therapeutic window” (Parrish, 1981), where the
relatively low absorption and the predominantly forward-
directed scattering of tissue (Wilson and Patterson, 1986;
Flock et al., 1987; Jacques et al., 1987) permits substantially
increased penetration of the excitation light into the tissue
and enhanced escape (i.e., remittance) of the fluorescent
photons from tissue. In addition, the interference from
autofluorescence in tissue is reduced in this wavelength
region.
It has been known that multiple scattering effects of both
excitation and emission light can perturb quantitative mea-
surements of fluorescence calcium indicators (Brandes et
al., 1994). The conventional methods using dual-wave-
length fluorescence excitation or emission for ratio mea-
surements have been used to extract [Ca2]i based on a
spectral shift in either the excitation or emission spectrum
upon binding Ca2 (Grykiewicz et al., 1985; Brandes et al.,
1993; Field et al., 1994). This fluorescence ratio technique
can eliminate the influence of dye concentration change and
minimize the errors induced by tissue scattering, tissue
absorption, and motion artifacts (Koretsky et al., 1987;
Fralix et al., 1990; Brandes et al., 1992). However, many of
the visible light-excited calcium fluorescence dyes that are
readily available do not exhibit a spectral shift upon calcium
binding (Haugland, 1996). For example, Fig. 1 shows the
absorption and fluorescence emission spectra of Rhod-2 (10
M) in aqueous solution with various Ca2 concentrations
(0.04–40 M). It is clear that increasing the Ca2 concen-
tration only causes an increase of the fluorescence intensity,
and no spectral shift in excitation and emission. This pre-
cludes the use of the conventional fluorescence ratiometry
mentioned above, thus making the quantification of [Ca2]i
using Rhod-2 a challenging problem.
To enable the use of Rhod-2 as a calcium indicator in
perfused hearts, Del Nido et al. (1998) proposed an empir-
ical approach to quantify the concentration of Rhod-2 in
perfused rabbit heart by measuring the reflected absorbance.
This approach was based on the finding that the ratio of the
fluorescence to absorbance was unchanged with the con-
centration change of Rhod-2 in the heart; thus the fluores-
cence-to-absorbance ratio was used to measure the change
in the quantum yield of Rhod-2 with changes in [Ca2]i in
the perfused rabbit heart. Substantial work needs to be done
both theoretically and experimentally to validate this
method, particularly in the presence of tissue scattering.
Also, the possible spectral distortions caused by the inter-
play of factors such as tissue scattering, absorption, and the
detection geometry, as well as their impact on quantitation
accuracy, need to be further investigated.
In this study we extend the Rhod-2-based Ca2 measure-
ment to the perfused mouse heart. To systematically analyze
the influence of tissue optical properties (e.g., scattering and
absorption) on [Ca2]i determination, analytical models for
the absorbance and fluorescence spectra are derived within
the framework of photon diffusion theory. Our model pre-
dicts a proportional decay of the fluorescence and absor-
bance intensities as a result of Rhod-2 washout, thus veri-
fying that the fluorescence-to-absorbance ratio can be used
to compensate for the influence of the Rhod-2 concentration
changes on [Ca2]i measurement in the heart. Moreover, we
demonstrate that the fluorescence-to-absorbance ratio as a
FIGURE 1 Absorption (dashed curve) and Ca2-dependent fluorescence
(solid curves) spectra of Rhod-2 (10 M) in solutions with various Ca2
concentrations (0.04–40 M).
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measure of quantum yield in the [Ca2]i calculation can
eliminate the distortions induced by tissue optical properties
and geometrical complications. The results of our modeling
are confirmed by experiments with Rhod-2 infusion into the
perfused mouse heart.
THEORY
The mouse heart, like most biological tissue, has marked
light-scattering properties. The light incident into it will
undergo not only absorption, but also multiple scattering
events; a quantitative analysis of the detected optical signal
from an illuminated, perfused mouse heart is very compli-
cated. This is because both fluorescence excitation and
emission will involve photon diffusion, in which multiple
light-scattering effects will affect the measured absorbance
and fluorescence spectra. To address this challenging prob-
lem, on the basis of the theory of photon diffusion approx-
imation we derive the analytical models for absorbance and
fluorescence spectra from tissue.
Diffuse reflectance
Because the basic measured quantities in our experimental
setup are the diffuse reflectances at the excitation and emis-
sion wavelengths, our first task is to derive a model that can
establish the relation between the reflectance and the absor-
bance of the fluorophore in the presence of scattering. For
simplicity, we assume that the tissue is a homogeneous
medium with a semi-infinite geometry. Then, the light prop-
agation in the tissue can be described by the diffusion
approximation, i.e., given by the diffusion equation (Ishi-
maru, 1978; Patterson et al., 1989; Yodh and Chance,
1995):
D
2rar	 Sr (1)
where (r) represents the photon fluence rate at position r
(
, z), where 
 is the radial distance from the incident beam
and z is the depth within tissue. S(r) is the photon source in
the tissue; D  [3s]1 is the diffusion coefficient for a
turbid medium, such as biological tissue (Patterson et al.,
1989); and a, s are the optical absorption coefficient and
the reduced scattering coefficient of tissue, respectively.
As has been described elsewhere (Patterson et al., 1989;
Farrell et al., 1992), a Green function can be used to
approximate (r) produced by a point source incident at
(0, z0) for an infinite tissue boundary. The solution to a
semi-infinite boundary condition, a good analog to our
experimental illumination, is deduced by adding a negative
or image source to the infinite case (Eason et al., 1987;
Patterson et al., 1989):

, z	
1
4De
effr1
r1

eeffr2
r2  (2)
where r1  [(z  z0)2  
2]1/2 and r2  [(z  z0)2  
2]1/2;
eff  [3a(a  s)]1/2 is defined as the effective attenu-
ation coefficient, and eff  1/eff represents the effective
penetration depth that characterizes the penetration of dif-
fuse light into the tissue.
From Eq. 2, the measured diffuse reflectance from the
tissue surface at (
, 0) can be given by calculating the
photon current leaving the tissue at z  0
R
	D
z0	
z0
2eff 1z02 
2e
effz02
2
z02 
2
(3)
where the parameter z0 represents the diffusion range, i.e.,
the depth at which scattering events are assumed to produce
an isotropic point source. It equals the reduced mean free
path mfp  1/(a  s) traveled by photons in tissue. For
a pencil beam (e.g., focused beam) of strength S0 incident
normal to the tissue surface, the source distribution inside
the tissue is S0[z0  1/(a  s)] (Eason et al., 1987).
Hence, the total diffuse reflectance from the tissue can be
calculated by integrating Eq. 3 for the whole source distri-
bution and along the surface,
R	 
0

0

R
S0z0 1as	dz02
d

	 S0
s
as
1
1 31 sas
(4)
This is the basic analytical expression that will be used
below to derive the absorbance caused by the presence of
fluorescent dye in the perfused mouse heart.
Absorbance induced by the fluorescent
dye in tissue
If we assume that the fluorophore is distributed homoge-
neously within the tissue, the concentration of fluorophore
can be derived from the measured diffuse reflectances be-
fore and after fluorophore injection. It is quite usual and
convenient to present the results in terms of absorbance A,
which is given by
A 	 log10
R0
R (5)
where R0 and R are obtained pre- and post-loading of
fluorescence. In our experiments, the additional optical ab-
sorption due to the fluorophore presence in the tissue is
much less than that of tissue itself; the resultant change in
the detected reflectance is so small that it can be expressed
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as (Patterson et al., 1989)
A 	0.434af
d
da
loge R (6)
where af  C is the absorption coefficient of the flu-
orophore in tissue; C and  are the concentration and the
extinction coefficient of fluorophore at the wavelength .
It should be pointed out that only the change of absorp-
tion induced by the presence of the fluorophore is consid-
ered in the derivation of Eq. 6. As a matter of fact, the
reflected light is attributed to the photons propagating
through and re-emitted from scattering tissue, the variation
of tissue scattering induced by fluorophore presence could
result in an additional error in the detected A. This effect
could be significant in the perfused beating heart because
the perfusate is changed from one without to one with
Rhod-2. For instance, Fig. 2 A shows the absorbance spec-
trum after loading Rhod-2 into the mouse heart. The absor-
bance was obtained according to Eq. 5, which compares the
observed reflectance with that before Rhod-2 loading. As
we expected, the infusion of Rhod-2 into the heart induces
a significant increase in absorbance at 524 nm, because
Rhod-2 absorbs light at this wavelength. However, a small
increase in absorbance is also visible in the emission band
longer than 580 nm, though Rhod-2 does not absorb light in
this range. This is presumably due to the change in tissue
scattering associated with the presence of Rhod-2 in the
perfusate. As indicated in Fig. 2 A, this spurious change
caused by the change of scattering in the tissue results in
25% overestimation of the Rhod-2 absorbance in the
Rhod-2 absorption band (e.g., at 524 nm). It may vary with
time and from subject to subject, and so must be accounted
for.
If the artifacts due to changes in tissue scattering during
perfusion are further taken into account, Eq. 6 can be
rewritten as
A 	 	a
log10R
a
 	s

log10R
s
	af
 a
  	s
s
 (7)
The first term on the right-hand side of the equation denotes
the contribution of the absorption change to the detected
absorbance A when tissue scattering is unchanged (i.e., s
is constant). The second term denotes the influence of the
change in tissue scattering when a is constant. It is quite
clear that Eq. 6 is an approximation of Eq. 7 under the
assumption that the variation induced by tissue scattering is
negligibly small.
The coefficients a and s in Eq. 7 can be derived by
differentiating Eq. 4 in logarithmic scale with respect to a
and s to give,
a
 	
log10R
a


s
	0.4343D 32 effR

(8)
s
 	
log10R
s


a
	 0.4343D 32 effR

Substituting Eq. 8 into Eq. 7 yields,
A 	 0.434af 3D
3
2 effR

	s
 3D 32 effR
 (9)
The equation relates the absorbance to the variations of
absorption and scattering of tissue due to the infusion of
fluorophore. It can be seen that the measured absorbance
will be modified by the scattering changes due to fluoro-
phore infusion and needs to be corrected. To remove the
second bracket on the right-hand side in Eq. 9, we use a
relative, two-wavelength absorbance method pioneered by
Chance (1951). If the reflected intensities at the wave-
lengths of 1 and 2 are detected, the relative absorbance
FIGURE 2 Reflected absorbance (A) and excitation spectrum (B) of
Rhod-2 from the perfused mouse heart. A was obtained according to Eq. 5;
B was obtained from the excitation spectral ratio between post- and
pre-loading of Rhod-2.
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difference between these wavelengths is:
A1,2	 log10
R1
R2 (10)
and can be rewritten as,
A1,2	 	a
1a
1 	a
2a
2
 	s
1s
1 	s
2s
2 (11)
if a similar mathematical derivation is applied as used to get
Eq. 9. This equation can be further simplified for the case in
which the scattering properties of tissue are approximately
identical at 1 and 2 before adding fluorescent dye. Two
such wavelengths can be found because in the visible and
NIR range, s is a slow-varying function of wavelength
(Cheong et al., 1990). For 1  2  100 nm in our
experiment, it can be assumed that 	s1  	s2, D1 
D2, and eff1  eff2. By choosing 2 such that the fluoro-
phore does not absorb, i.e., 	a2  0; then Eq. 11 can be
rewritten as:
A1,2	 	a1a1 	ss1 s2
	 0.434af13D
3
2 effR
1
 	s
3
2 effR
1 R2 (12)
This equation reveals that an appropriate selection of the
wavelengths 1 and 2 so that the reflected intensities at
these wavelengths are close (i.e., R1  R2) can eliminate
the influence of tissue scattering changes as represented by
the second term in Eq. 12. This leads to the simplified
relation:
A1,2	 log10
R1
R2	 0.434 af
13D 32 effR
1 (13)
Equation 13 provides a useful model to analyze the relation
of the absorbance in the excitation band with the optical
properties of tissue and fluorophore in highly scattering
tissue.
Fluorescence emission from tissue
In principle, the diffusion theory can also be used to de-
scribe the propagation of fluorescence light in a scattering
tissue if a proper model is used to simulate the fluorescence
source for Eq. 1.
In scattering tissue, the source term for the fluorescence
emission Sm(r) at position r is proportional to the exci-
tation light absorbed by the fluorophores at r (i.e.,
af
xNx(r)) and the quantum efficiency x,m of fluores-
cence, which is excited at x and emitted at m. To obtain
the fluorescence that reaches the surface at position r, i.e.,
Fx,m (r), one must calculate the fluorescence photon den-
sity Nf(r) or the fluence rate f(r)  cNf(r) (c is the speed
of light in tissue). This can be derived by spatially convolv-
ing Sm(r) with the escape function Em(r  r) of the
fluorescence light,
Nfr	afxx,m
r
Nxr Emr rdr (14)
where r  (
2  z2)1/2 varies with the variables 
 in the
horizontal direction and z in the vertical direction. Thus, this
convolution is actually a two-dimensional integral and is
analytically unsolvable without appropriate approximations.
To tackle this problem and obtain an analytical solution to
Eq. 14, one approach is to simplify the convolution to one
dimension only in the z direction, assuming that both Nx
and Em decrease exponentially as a function of z either
with empirical attenuation coefficients or within diffusion
approximations (van der Putten and van Gemert, 1983;
Potter and Mang, 1984; Gmitro et al., 1988; Richards-
Kortum et al., 1989). The alternative is to use the photon
migration method to derive the relationship of photon den-
sities (i.e., fluences) between the fluorescence excitation
and emission, thus circumventing the complexity of the
convolution calculation (Wu et al., 1993; Patterson and
Pogue, 1994). As has been described elsewhere (Patterson
and Pogue, 1994), in the case of a continuous-wave excita-
tion, the fluorescence photon density Nf(r) can be given by
Nfr	
af
xx,m
a
xa
m Nmr Nxr (15)
where Nm(r) is the excitation photon density that would be
observed if the excitation wavelength were changed to m.
The fluorescence emission from the tissue surface at (0, 
)
can be derived as a summation of all the photon currents
leaving the tissue from there,
Fx,mrz0	D
cNfrz0
	
af
xx,m
a
xa
m Rm
 Rx
 (16)
The total fluorescence emission over the entire tissue sur-
face can be acquired by a spatial integration over the entire
surface as a summation of all lateral positions 

Fx,m	
af
xx,m
a
xa
m Rm Rx (17)
where ax  x  afx, am  m  afm are the total
absorption coefficients at the excitation and emission wave-
lengths of x and m, respectively. Rx and Rm are the total
reflectances at x and m in the presence of fluorophore in
tissue.
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EXTRACTING FLUORESCENCE QUANTUM YIELD
FOR [Ca2]i DETERMINATION
The model analysis has been general so far, in the sense that
neither the specific optical properties of the Ca2 probe nor
those of the heart tissue have been considered in the above
derivation. In this section, however, the optimal selection of
the wavelengths used for the absorbance and fluorescence
detection by which the Ca2 is measured by using Rhod-2
in perfused heart will be discussed. For this purpose, the
ratiometric method evaluating the fluorescence-to-absor-
bance ratio is introduced to extract the quantum yield
x,m of the Ca2-dependent fluorescence. As a conse-
quence, this ratio, F/A, is independent of the probe concen-
tration in the heart, thus making Rhod-2 a quantitative
calcium indicator. More importantly, our theoretical mod-
eling demonstrates that F/A can be used to determine the
concentration of cytosolic calcium [Ca2]i, and the distor-
tion induced by the tissue optical properties and the detec-
tion geometry are eliminated.
Optimal selection of absorbance and
fluorescence wavelengths
Although the Ca2-sensitive probe, Rhod-2, is excited and
emitted in the visible range of 500–630 nm where tissue
chromophores (mainly myoglobin in perfused heart) absorb
much less light than in the UV range, the tissue optical
properties (absorption and scattering) still play an important
role in the excitation and fluorescence detection. This so-
called “inner filter” effect, to a great extent, depends on
tissue oxygenation. Fig. 2 B is the fluorescence excitation
spectrum from a perfused heart. Unlike in calcium solution
where Rhod-2 exhibits higher fluorescence emission excited
at 548 nm because of a higher absorption at this wavelength,
in heart tissue the excitation at 524 nm is more efficient than
at 548 nm as a result of inner filtering by the tissue. Fig. 3 A
shows the reflected-absorption spectra obtained from the
surface of a perfused mouse heart with varying oxygenation
state from normoxic to hypoxic. Fig. 3 B indicates the
isosbestic wavelengths of 524, 548, 568, and 589 nm for the
heart tissue, determined by comparing the normoxic and
hypoxic spectra. Fig. 3 C shows the fluorescence spectra of
Rhod-2 measured from the heart in both normoxia and
hypoxia, respectively. It demonstrates that the fluorescence
intensity of Rhod-2 changes with the oxygenation of the
heart, except at the isosbestic wavelengths.
To minimize the influence of the tissue absorption
changes caused by the oxygenation status of the heart on
absorbance and fluorescence detection, two isosbestic
wavelengths are needed for fluorescence excitation and
fluorescence emission, respectively. However, the absor-
bances at these two wavelengths are required to be nearly
equal to eliminate the influence of tissue scattering. In this
study, x  524 nm and m  589 nm are chosen as
excitation and emission wavelengths, respectively. These
two wavelengths are also used as 1 and 2 for the deter-
mination of the differential absorbance A1,2 by using Eq.
13. The rationales for and importance of selecting these two
wavelengths are as follows:
1. Rhod-2 absorbs light at 524 nm and does not absorb at
589 nm, thus satisfying the requirement specified in Eq.
13, i.e., 	a1  0, and 	a2  0;
2. m x 100 nm, the difference of the tissue scattering
properties at the excitation and emission wavelengths is
FIGURE 3 Fluorescence excitation, emission, and absorbance measure-
ments are chosen at the isosbestic wavelengths (circles) of myoglobin to
minimize the effects of tissue absorption change caused by oxygenation
changes in the Rhod-2 loaded heart. (A) Reflected absorption spectra from
oxygenated heart (dashed line) and deoxygenated heart (solid line). (B)
Difference in absorption spectrum of a heart in oxygenated and deoxygen-
ated state. (C) Fluorescence spectra obtained from oxygenated heart
(dashed line) and deoxygenated heart (solid line).
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negligible (Cheong et al., 1990), the differences of D and
	s between these two wavelengths can be ignored;
3. The reflectance spectra of heart tissue at these two wave-
lengths are approximately equivalent; in other words,
R1  R2, and the second term on the right-hand side of
Eq. 12 representing the change in tissue scattering can be
neglected. The influence of the fluctuation in tissue
scattering on A1,2 can thus be minimized;
4. At these two wavelengths, both scattering and absorption
(excluding fluorophore) of heart tissue are approxi-
mately equal; therefore, the penetration depths should be
approximately the same according to eff  [3a(a 
s)]1/2;
5. Both 524 and 589 nm are isosbestic wavelengths; thus, the
influence of tissue absorption change due to tissue oxygen-
ation on the optical measurements is minimized. Further-
more, the change in absorbance at 524 nm with oxygen-
ation is smaller than at 548 nm (see slope in Fig. 3 B).
Fluorescence-to-absorbance ratio
As discussed above, 524 and 589 nm are specified as
excitation and emission wavelengths to measure the Ca2-
dependent fluorescence in the perfused heart. The fluores-
cence emission given in Eq. 17 can be simplified as
Fx,m	x,m1afx
	R
	a
x,m1afx
dR
da
	af
xx,mRx3D 32 effR
x (18)
It is almost impossible to collect the total emission over the
entire tissue surface without utilizing an integrating sphere.
However, to avoid the strong specular reflectance due to
mismatch of reflective index at the interface between air,
glass, and tissue, the detection optics is chosen to have a
deflection angle of F off the normal direction of the inci-
dent beam. With a solid angle of F, the fluorescence
intensity collected by the detection system is a portion of the
total emission multiplied by a geometric factor G(F, F)
( F/2 cos F) according to Lambert’s law (Wilson and
Jacques, 1990). Therefore, for the fluorescence detection
geometry with a G(F, F) used in our experiment, Eq. 18
becomes
Fx,m	 GF , Fafx
x,mRx3D 32 effR
x (19)
Combining Eqs. 13 and 19 and applying 1  x and 2 
m yields
F
A	
Fx,m
A1,2 	 0.434
1GF , FRxx,m (20)
This equation indicates that the ratio F/A remains propor-
tional to the quantum yield , while the absorption coeffi-
cient afx is excluded by this ratio calculation. This implies
that the influence of Rhod-2 concentration washout during
perfusion can be eliminated by this ratiometric method. It
must also be noted that the geometry factor G disappears in
the expression of A1,2. This is because the reflectances at
these two wavelengths are measured with the same detec-
tion optics, and the geometric factors affecting the absolute
signals at each wavelength can be eliminated by their ratio
in terms of A1,2 in Eq. 10.
[Ca2]i determination
The ratio F/A can be used to calculate cytosolic calcium
concentration [Ca2]i by the following equation:
Ca2i	 Kd
Ftx,m
At1,2
Fmaxx,m
Amax1,2

Ftx,m
At1,2
(21)
where Kd  710 nM is the dissociation coefficient for
Rhod-2 and calcium calibrated in vitro (Del Nido et al.,
1998). Ft and At denote the Ca2-dependent fluorescence
and differential absorbance at the excitation and the emis-
sion wavelengths at time t. Fmax is the maximal fluores-
cence calibrated in situ by tetanizing the heart at high
perfusate calcium in the presence of a sarcoplasmic reticu-
lum ATPase inhibitor, and Amax is the absorbance during
tetanization. Equation 21 assumes that Fx,m is zero at
[Ca2]i  0 due to a 100-fold change in the fluorescence
with calcium binding of Rhod-2 (Haugland, 1996). There-
fore, the minimal fluorescence is assumed to be equal to the
background fluorescence (Del Nido et al., 1998). Ft and
Fmax can be obtained by subtracting the background fluo-
rescence before Rhod-2 loading from the fluorescence
intensities.
It should be pointed out that, although the ratio F/A is
affected by the factors Rx and G as indicated in Eq. 20, the
influence of these factors can be eliminated in Eq. 21 for
[Ca2]i determination provided that they are unchanged or
measured during the experiment and during determination
of the maximal fluorescence calibration.
MATERIALS AND METHODS
Experiments were performed to verify the predictions of Eq. 20 and to
validate Eq. 21 for the quantification of cytosolic calcium in the perfused
mouse heart. In this section we describe the perfused mouse heart prepa-
ration and the experimental apparatus and procedures, with emphasis on
the detection of the reflected absorbance and fluorescence from the per-
fused heart. To assess motion-induced artifacts of the beating heart and to
ensure heart oxygenation, a noninvasive technique was introduced in our
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experiment to monitor NADH and the absorption spectrum of the heart
before Rhod-2 loading.
Mouse heart perfusion
The isolated mouse heart was perfused using the Langendorff method in a
water-jacketed chamber at 37°C, and stimulated at 8 Hz. A balloon was
inserted into the left ventricular cavity to monitor developed pressure
simultaneously with the Rhod-2-labeled calcium transient. To suppress
motion-induced artifacts and minimize the effects from the curvature of the
epicardium, the mouse heart was gently placed against the optical window
inside the chamber by immobilizing the perfusion cannula above the heart.
Apparatus
Optical experiments were performed using an SLM spectrofluorometer
(Aminco SLM 8000, SLM Co., Springfield, IL). The light source used was
an arc lamp connected to a computer-controlled monochromator to select
the excitation wavelength within the region of 300–800 nm. After passing
through a beam-splitter that reflects4% of the incident light for reference
detection, the transmitted light was delivered onto the heart surface with a
2 mm beam spot. The fluorescence emission was collected with a biconvex
lens (f 50 mm) placed at 90° off the excitation beam, filtered by a second
monochromator, and then detected by a cooled photomultiplier tube (PMT-
F). To avoid the specular reflection from the air-glass-tissue interfaces, the
perfusion chamber was positioned at 30° off the excitation beam. A
long-pass filter (LPF) with a cutoff wavelength at 540 nm was inserted in
front of the emission monochromator to block the scattered excitation
photons, including the stray light from the slightly curved heart surface.
The reflected diffuse light from the heart tissue was collected by a focal
lens (f  30 mm), mounted at 45° off the normal direction of the window
plane to avoid the specular reflection. It was then delivered to another
photomultiplier tube (PMT-A) through a flexible liquid light guide (Oriel
Co. 77568, Stratford, CT). To eliminate the errors induced by the source
intensity fluctuation, the fluorescence and reflectance signals were instan-
taneously compared to the reference signal by a reference PMT. These
signals are acquired and stored in a computer via an A/D converter.
Compensation of motion- and oxygenation-
induced artifacts
The motion of a beating heart can introduce a motion artifact affecting the
measured Ca2 fluorescence transient signal. Previous studies proposed
improved chamber designs (Salama et al., 1987; Efimov et al., 1996) and
an internal fluorescence standard to minimize this artifact and avoid
ischemia (Koretsky et al., 1987). These methods required either compli-
cated chamber design and precise pressure control or additional fluorescent
dye infusion. In this study a simple and direct method is proposed, allowing
utilization of a conventional water-jacketed bath (FP-295, Spectronic In-
strument, Urbana, IL). As will be discussed later, this technique is based on
our observation that the NADH emission at 465 nm exhibited a waveform
whose amplitude is proportional to the heart’s contractile motion. There-
fore, the NADH signal acquired over several cardiac cycles permitted
optimal adjustment of heart position and tension to minimize motion
artifacts. Because the heart was gently placed against the window by fixing
the perfusion cannula, this method has proven effective in maintaining
normal physiological function in the perfused heart.
To monitor the oxygenation state of the heart, the reflected absorbance
spectrum between 500 and 600 nm was measured together with the ratio of
NADH fluorescence at 465 nm (excited at 365 nm) to the autofluorescence
at 589 nm (excited at 524 nm). As discussed later, these parameters can be
used to determine if the oxygenation state of the heart is adequate at the
beginning of the experiment.
Fluorescence and absorbance measurements
During the experiment, 100 g Rhod-2 (Molecular Probes, R-1243, Eu-
gene, OR) was dissolved in 4 l dimethylsulfoxide (DMSO) and 200 l
water, then mixed with 9 ml oxygenated Krebs solution and bolused
through the perfusate. The Rhod-2 was added to a parallel perfusion line
connected to the same reservoir. During bolusing the bolus line was opened
and the other line was closed. This method resulted in no change in the
important coronary flow rate, which averages at 1.9  0.4 ml/min. Thus,
the bolus concentration of Rhod-2 was 11 g/ml and was infused for 4–5
min. The precise time depended on the coronary flow for an individual
heart. Loading of Rhod-2 resulted in a 6.2  1.9-fold increase (n  24) in
fluorescence over background fluorescence at the end of the 20–25 min
washout period. Subsequently, Ca2-dependent fluorescence transients
along with the corresponding left ventricular pressure signals were ac-
quired at a sampling rate of 15 ms per point to provide 8 points per
cardiac cycle (stimulation rate  8 Hz). At each data point, signal aver-
aging was performed to reduce noise. To normalize the change of fluores-
cence signal due to Rhod-2 washout through the perfusate, the reflected
absorbance spectrum was scanned from 500 to 600 nm in 15 s and the
absorbance ratio between 524 nm and 589 nm was determined using Eq.
10. After five fluorescence and absorbance measurements were taken, the
maximal calcium-dependent fluorescence signal was calibrated in situ
using a high concentration of calcium perfusate (20 mM calcium chloride)
with the sarcoplasmic reticulum Ca2-ATPase inhibitor, cyclopiazonic
acid (10 M, Sigma Chemical Co., St. Louis, MO) to tetanize the heart and
saturate Rhod-2 with calcium (n  20). Simultaneously, the diffuse reflec-
tance was recorded to correct the effects due to scattering changes in the
heart tissue. [Ca2]i was calculated using Eq. 21, in which Ft and Fmax are
the fluorescence intensities after subtracting the background autofluores-
cence before Rhod-2 loading.
The cyclopiazonic acid tetanization method was compared to the digi-
tonin tetanization method, as used by Del Nido et al. (1998). In n  4
experiments, digitonin (10 m) was mixed with 9 ml perfusate and loaded
through the coronary circulation into the heart.
To examine whether the changes in tissue scattering due to perfusate
changes are wavelength-independent, graded concentrations of manganese
chloride (MnCl2, 25–1000 m, n  12) were infused into the heart after
Rhod-2 loading. The absorbance spectrum within the wavelength of 500–
600 nm was recorded after each administration.
RESULTS
Motion suppression and oxygenation
state of the heart
Fig. 4 is a representative experiment showing the use of
NADH fluorescence for suppression of motion-induced ar-
tifacts. Fig. 4 A shows that the background fluorescence at
589 nm, Bb589, is too low to be useful to monitor motion-
induced artifact before Rhod-2 loading. However, it can be
seen in Fig. 4 B that the NADH emission, BNADH465 , varies
with heart contractile motion (180 phase delay), and was
significantly reduced in amplitude when the heart was ap-
propriately immobilized against the optical window (see
Fig. 4 B, right) with improvement in the fluorescence tran-
sient signal as illustrated in Fig. 4 C. This suggests that
BNADH465 provides a simple and immediate estimation of the
motion-induced noise. In 16 hearts motion-induced artifact,
as determined by variation in NADH autofluorescence, was
4.6  1.2% from immobilized hearts. This was calculated
by using 	BNADH465 /BNADH465 , where 	BNADH465 is the NADH
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variation amplitude and BNADH465 is the normalized mean
NADH autofluorescence intensity.
Fig. 5 A shows that myoglobin oxygenation markedly
affects the ratio A550/A580, where A550 is the absorption peak
at 550 nm (deoxy-sensitive) and A580 is that at 580 nm
(oxy-sensitive). These data were obtained from a group of
hearts, some of which inadvertently had low coronary
flows. When perfusing mouse hearts we have noticed that
occasionally hearts are dysfunctional related to low coro-
nary flows that reduce oxygen delivery to the heart. Thus,
this spectral ratio A550/A580 permits real-time monitoring of
the oxygenation of the mouse heart tissue during the exper-
iment. Also, BNADH465 varies with the oxygenation state,
whereas Bb589 measured at the isosbestic point of 589 nm is
oxy-insensitive, so that BNADH465 /Bb589 provides another mea-
sure of monitoring the oxygenation state of the heart. The
relationship between BNADH465 /Bb589 and A550/A580 obtained
from 20 hearts is illustrated in Fig. 5 B. Mouse hearts were
considered well-oxygenated if BNADH465 /Bb589  6 or A550/
A580  1. Thus, we now use the absorbance spectra at the
beginning of the experiment to determine whether a heart is
well-oxygenated.
Rhod-2 washout and fluorescence-
absorbance normalization
Fig. 6 A, left shows the calibrated absorbance spectra during
the washout period, e.g., 25 min after Rhod-2 was loaded,
which were obtained by using Eq. 10 with 2  589 nm.
Fig. 6 A, right shows the corresponding fluorescence spec-
tra of Rhod-2 from the same heart. Both figures clearly
indicate that Rhod-2 gradually leaks out of the heart tissue,
resulting in a decrease in A524,589 and F524,589.
In Fig. 6 B the closed circles show the decay of the
absorbance A524,589 during the washout period, whereas the
open circles show the decay of the mean fluorescence
F524,589. It can be seen that A524,589 decreases in proportion
with F524,589 during dye washout; in other words, with
Rhod-2 concentration. This result confirms our theoretical
predictions in Eqs. 13 and 19. Fig. 6 C shows the ratios of
F/A with excitation at 524 or 548 nm. As illustrated by the
squares in Fig. 6 C, F524,589/A524,589 is independent of the
washout time or Rhod-2 concentration, thus confirming the
feasibility of the ratiometric technique, i.e., Eq. 20, which
we propose to effectively eliminate the influence of dye
concentration changes induced by heart perfusion on the
[Ca2]i determination. To determine which isosbestic wave-
length is optimal, we also plot the ratio of F548,589/A548,589
as a function of time in Fig. 6 C. In n  3 experiments, the
mean change in F548,589/A548,589 was 15.1  5.3% over 20
FIGURE 4 Identification of motion artifacts by monitoring NADH
autofluorescence before Rhod-2 loading, allowing optimization of motion
suppression by positioning of the heart. Background fluorescence emission
at 589 nm (A) excited at 524 nm, autofluorescence of NADH at 465 nm (B)
excited at 365 nm obtained from the heart before loading Rhod-2, and the
comparison of Ca2-dependent fluorescence transient signal before and
after motion suppression (C). Note that these data have been normalized to
their maximum values for comparisons before and after positioning the
heart.
FIGURE 5 Monitoring of myocardial oxygenation of the perfused
mouse hearts before loading Rhod-2. (A) Effects of the oxygenation state
of myoglobin on the reflected absorption peaks of 550 and 580 nm. The
oxygenation state was seen to vary with coronary flow. Occasionally, when
perfusing hearts poor oxygenation is seen related to low coronary flow
(A1  1.9  0.4 ml/min, A2  1.3  0.25 ml/min, and A3  1.1  0.26
ml/min). Thus, in hearts with higher coronary flows a lower ratio of
A550/A580 is seen. (B) Relationship of the measured fluorescence ratio
BNADH465 /Bb589 and absorbance ratio A550/A580.
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min with dye washout, whereas with F524,589/A524,589 this
was only 2.0  1.5%, indicating that F548,589/A548,589 was
dependent on dye concentration, unlike F524,589/A524,589.
Tissue scattering change during Mn2 infusion
and corrected Fmax
Equation 13 is validated under the assumption that the
change of tissue scattering-properties due to perfusate
changes are approximately identical at wavelengths of 1
and 2. To investigate this hypothesis, we measured the
changes of reflectance spectra while adding various doses of
manganese. Fig. 7 shows an example illustrating that the
overall spectral absorption within 500–600 nm decreases in
a wavelength-independent manner with [Mn2]. As we
found that increasing [Mn2] did not modulate the absorp-
tion spectrum of Rhod-2, this decrease must have resulted
from a change of pathlength L within the narrow band of
500–600 nm due to Mn2 perfusion, which was dose-
dependent. We believe that adding Mn2 introduces a slight
osmotic pressure gradient between the intra and extracellu-
lar fluid and causes cellular volume changes, thus resulting
in an increase in tissue scattering. Similar observations have
been reported with liver perfusion (Chance et al., 1995).
This previous study proposed a linear relation between 	L
and 	s (Liu et al., 1996); therefore, it is a reasonable
assumption that the change of tissue scattering is wave-
length-independent, i.e., 	s1  	s2 within the 500–
600 nm range.
Similar changes in tissue-scattering properties have been
found at the three isosbestic wavelengths of 524, 548, and
589 nm during heart tetanization, and Fig. 8 B shows typical
time-dependent reflectance R524 and fluorescence Fmax524,589
traces. At the isosbestic point of 524 nm, the increase of
R524 must be caused by tissue scattering rather than endog-
enous absorption due to any oxygenation changes or myo-
globin leaking out of cells because the absorbance spectra
before and after tetanization overlap at the isosbestic points,
as shown in Fig. 8 A. This change in tissue scattering is
likely due to hypoxia and contraction during tetanization,
resulting in changes in tissue properties such as cell size or
refractive index differences between intra and extracellular
fluid. This increase in tissue scattering results in an increase
in R524 and Fmax524,589, in addition to that resulting from an
increase in  due to increased Ca2 (see Eq. 19).
The influence of this increase in R524 on Fmax524,589 can be
corrected effectively by multiplying Fmax524,589 with the ratio of
R524 pre- to post-tetanization. The corrected Fmax524,589 over
Amax524,589 results in a steady-state maximal value as shown in
Fig. 8 B, which is used in Eq. 21 for the [Ca2]i determination.
For comparison, Fig. 9 shows heart tetanization with
digitonin. As we can see from Fig. 9 B the fluorescence
FIGURE 6 An example of the effects of Rhod-2 washout from the heart
on absorbance and fluorescence signals. (A, left): Absorbance spectra of
Rhod-2 at time t0 and t1, calibrated at 2 589 nm using Eq. 10; (A, right):
Ca2-dependent fluorescence spectra of Rhod-2 at the same time when
excited at 524 nm, in which the background fluorescence is subtracted. (B)
Changes of Ca2-dependent mean fluorescence F524,589 (open circle, ob-
tained by time-averaging transients), and absorbance A524,589 (closed cir-
cle) as a function of time. (C) Fluorescence emissions at 589 nm when
excited at 524 nm (solid squares), or at 548 nm (open diamond) normalized
by the corresponding absorbances, indicating the independence of F524,589/
A524,589 on Rhod-2 washout.
FIGURE 7 Reflected absorption spectra obtained from the mouse heart
with Mn2 infusion from [Mn2]  0 (solid line), 200 (dashed line), to
1000 M (dotted line).
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reaches a maximal value in 5 min after tetanization (Fmax
uncorrected 282 63%) and then decreases significantly
along with an increase in R524, so that at 25 min fluores-
cence falls to 169  53%. Interestingly, the absorbance
spectrum after digitonin tetanization is very much flattened
in the myoglobin absorption range of 500–600 nm, as
shown in Fig. 9 A. Thus, the fluorescence decrease is likely
caused by wash out of cellular contents related to digitonin
permeabilization of surface membranes. For this reason, we
have preferred to tetanize the heart with cyclopiazonic acid
rather than digitonin, though there is no significant differ-
ence in the maximal fluorescence increase between the two
methods. The uncorrected Fmax with cyclopiazonic acid is
294  59%, and with digitonin is 282  63% (p  ns)
relative to the pre-tetanization mean fluorescence value. Of
note, because of the leakage phenomenon with digitonin we
cannot correct Fmax for the digitonin method. The corrected
Fmax for cyclopiazonic acid method is 223  40%, and it is
this value which is used in the calculation of intracellular
calcium concentration.
Ca2-transients in perfused mouse heart
Fig. 10 shows the normalized Ca2-dependent fluorescence
transient labeled with Rhod-2 and simultaneous left ventric-
FIGURE 8 (A) Comparison of absorbance spectra before and after teta-
nization with cyclopiazonic acid, normalized at 589 nm. Open circles
indicate the isosbestic wavelengths of myoglobin. (B) Changes of fluores-
cence F524,589 (dotted line) and reflectance R524 (dashed line) due to
changes in tissue scattering during heart tetanization. The corrected
F524,589 over A524,589 results in a steady maximum (solid line), thus
eliminating the influence of tissue scattering changes on the [Ca2]i
calculation using Eq. 21.
FIGURE 9 (A) Absorbance spectra before and after heart tetanization
using digitonin, normalized at 589 nm. Open circles indicate the isosbestic
wavelengths of myoglobin. (B) Changes of fluorescence F524,589 (dotted
line) and reflectance R524 (dashed line) during heart tetanization.
FIGURE 10 Calcium transients (top) represented by F/A (left y axis) or
calcium concentration (right y axis) with simultaneous recording of left
ventricular pressure (bottom).
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ular pressure tracing from a perfused mouse heart. It clearly
illustrates the upstrokes of the Ca2-transient during systole
and decline during diastole, and that the calcium transient
precedes the rise in left ventricular pressure. For a group of
four perfused mouse hearts, the Ca2-transient signals rep-
resent 33  9% of the diastolic fluorescence intensity. The
[Ca2]i calculated values are 368  68 nM and 654  164
nM in diastole and systole, respectively.
DISCUSSION
The results presented here validate the use of fluorescence
and absorbance measurements to quantitate Rhod-2 based
measurements of intracellular calcium in the isolated per-
fused mouse heart. The proposed methodology has potential
for other dyes that do not exhibit a fluorescence excitation
or emission shift, but a change in quantum efficiency pro-
vided that the assumptions for our theoretical derivation are
satisfied. Eq. 20 is accurate for quantifying the fluores-
cence-to-absorbance ratio of a fluorophore in scattering
tissue if the tissue is homogeneous with nonreentrant ge-
ometry. It also requires that changes in tissue scattering at
the excitation and detection wavelengths are nearly identical
(i.e., 	s1  	s2) and the measured reflectance R1 
R2. The assumption of 	s1  	s2 has been justified
for 2  1  100 nm in the visible and NIR range by
previous studies (Cheong et al., 1990), and is also confirmed
for mouse heart tissue by our experimental results presented
in Fig. 7. The requirement of R1  R2 was used in our
experiment to further eliminate the influence of 	s on the
detection of the absorbance ratio of A1,2, and was fulfilled
by a proper selection of 1 and 2.
It has been known that the isosbestic wavelengths are
useful for obtaining fluorescence and absorbance of a flu-
orophore and eliminating the interference of tissue filtration
due to changes in oxygenation state (Brandes et al., 1994).
  524, 548, 568, and 589 nm are the four measured
isosbestic points of mouse heart within the range of 500–
600 nm. Anyone of the first three, which are sensitive to
Rhod-2, can be selected for excitation, whereas 589 nm,
which is insensitive, can thus be used for emission detec-
tion. 524 nm was chosen for excitation rather than 548 or
568 nm because our in vivo study on mouse heart tissue
demonstrated that the quantum efficiency of fluorescence
emission at 589 nm is higher if excited at 524 nm (see Fig.
2 B). Another reason for choosing 524 nm for excitation is
that R524  R589. Fig. 6 C shows an example of comparison
of the ratios F524,589/A524,589 and F548,589/A548,589, obtained
from a perfused mouse heart during Rhod-2 washout. The
underestimation of F548,589/A548,589 in the first 20 min was
likely induced by a higher washout rate of A548,589 than that
of A524,589. This is presumably because of the mismatch of
spectral reflectance, or 	R548,589 is higher than 	R524,589,
resulting in a higher offset related to any changes in s
according to Eq. 12. Finally, changes in the heart oxygen-
ation state at 548 nm are greater than at 524 nm, as indicated
in Fig. 3 B. The change in optical density (OD) near 548 nm
is much steeper than that near 524 nm, making 548 nm
much more sensitive to changes in oxygenation than 524 nm.
A shortcoming of using Rhod-2 is that a measurement of
Fmax must be made on each heart. Previously, digitonin has
been used to saturate Rhod-2 with calcium (Del Nido et al.,
1998). Here we used cyclopiazonic acid and high calcium
perfusate and compared this to digitonin. Similar results
were obtained, however; the cyclopiazonic acid gave a
much better steady-state Fmax and there was little evidence
of leakage of Rhod-2 and myoglobin, as occurs with digi-
tonin. Errors in Fmax will lead to errors in the value of
[Ca2]i determined; for example, if Fmax is underestimated,
then the calculated [Ca2]i will be overestimated.
Calcium transient signals represent 33  9% of diastolic
fluorescence intensity. The calculated calcium concentra-
tion for perfused mouse heart were 368 68 nM and 654
164 nM in diastole and systole, respectively. These results
agree well with those previously reported using microinjec-
tion of aequorin in the mouse heart (Hampton et al., 1998).
It is important to note that we have not determined
subcellular localization of Rhod-2. Del Nido and colleagues
have shown that Rhod-2 was located in the cytosol and that
there was no evidence of mitochondrial deposition. How-
ever, other groups, such as Trollinger et al. (1997), have
found predominant mitochondrial loading. This apparent
discrepancy may be due to very different loading tech-
niques. Nevertheless, we cannot exclude that a portion of
the fluorescence is arising from mitochondria in this
method.
In conclusion, we demonstrate on both theoretical and
experimental grounds that measurement of quantum effi-
ciency changes of Rhod-2 with calcium binding can be used
to quantitate calcium concentration changes in the perfused
mouse heart.
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